Beam Therapeutics
(NASDAQ:BEAM)
$39.79
1.08[2.79%]
At close: Jul 1
$39.79
00
After Hours: 4:30PM EDT
Day High/Low38.29 - 40.13
52 Week High/Low27.77 - 138.52
Open / Close39 / 39.79
Float / Outstanding61M / 70.3M
Vol / Avg.1.1M / 1.4M
Mkt Cap2.8B
P/E-
50d Avg. Price36.61
Div / Yield-
Payout Ratio-
EPS-1.01
Total Float61M

Beam Therapeutics (NASDAQ:BEAM), Quotes and News Summary

Beam Therapeutics (NASDAQ: BEAM)

Day High/Low38.29 - 40.13
52 Week High/Low27.77 - 138.52
Open / Close39 / 39.79
Float / Outstanding61M / 70.3M
Vol / Avg.1.1M / 1.4M
Mkt Cap2.8B
P/E-
50d Avg. Price36.61
Div / Yield-
Payout Ratio-
EPS-1.01
Total Float61M
load more
Sector: Health Care.Industry: Biotechnology
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-09
REV
Q1 2022Est.ActualSurprise
EPS-1.320-1.010 0.3100
REV5.910M8.432M2.522M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Beam Therapeutics Questions & Answers

Q
How do I buy Beam Therapeutics (BEAM) stock?
A

You can purchase shares of Beam Therapeutics (NASDAQ: BEAM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Beam Therapeutics's (BEAM) competitors?
Q
What is the target price for Beam Therapeutics (BEAM) stock?
A

The latest price target for Beam Therapeutics (NASDAQ: BEAM) was reported by BMO Capital on Friday, June 17, 2022. The analyst firm set a price target for 41.00 expecting BEAM to rise to within 12 months (a possible 3.04% upside). 8 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Beam Therapeutics (BEAM)?
A

The stock price for Beam Therapeutics (NASDAQ: BEAM) is $39.79 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Beam Therapeutics (BEAM) pay a dividend?
A

A quarterly cash dividend of $0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.

Q
When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?
A

Beam Therapeutics’s Q2 earnings are confirmed for Tuesday, August 9, 2022.

Q
Is Beam Therapeutics (BEAM) going to split?
A

There is no upcoming split for Beam Therapeutics.

Q
What sector and industry does Beam Therapeutics (BEAM) operate in?
A

Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.